-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
KalVista Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from 2015 to 2023.
- KalVista Pharmaceuticals, Inc. Return On Equity for the quarter ending January 31, 2024 was -86.1 %, a 60.8% decline year-over-year.
- KalVista Pharmaceuticals, Inc. annual Return On Equity for 2022 was -43 %, a 40.6% increase from 2021.
- KalVista Pharmaceuticals, Inc. annual Return On Equity for 2021 was -72.4 %, a 46% decline from 2020.
- KalVista Pharmaceuticals, Inc. annual Return On Equity for 2020 was -49.6 %, a 42.2% decline from 2019.
Return On Equity, Quarterly (% [USD])
Return On Equity, YoY Quarterly Growth (%)